New Parkinson's drug shows promise in early trial for untreated patients
Symptom relief
Completed
This study tested a new drug called IkT-148009 in 137 adults with Parkinson's disease who were not taking any other Parkinson's medications. The goal was to see if the drug is safe and tolerable, and to measure its effects on movement and daily living symptoms over 12 weeks. Part…
Phase: PHASE2 • Sponsor: ABLi Therapeutics, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC